Table 2.
Univariate and multivariate analysis of various potential prognostic factors in gastric cancer patients
|
Factors |
Univariate analysis |
|
Multivariate analysis |
||
|---|---|---|---|---|---|
| Case NO. | HRb(95% CIc) | P | HRb(95% CIc) | P | |
| Age (<60/≥60) |
87/69 |
0.94(0.61-1.44) |
0.785 |
- |
- |
| Gender (male/female) |
106/50 |
1.17(0.74-1.84) |
0.511 |
- |
- |
| Differentiation (well, moderate/poor) |
77/79 |
0.79(0.46-1.74) |
0.381 |
- |
- |
| Therapeutic strategyd(Sur/Sur + Chemo) |
86/70 |
1.21(0.79-1.86) |
0.377 |
- |
- |
| Tumor size (≥5 cm/<5 cm) |
105/51 |
2.27(1.54-3.37) |
0.001a |
1.73(0.99-3.03) |
0.055 |
| Lymph node invasion (present/absent) |
111/45 |
1.55(1.25-1.92) |
0.012a |
1.05(0.73-1.53) |
0.780 |
| TNM stage (III-IV/I-II) |
108/48 |
1.95(1.48-2.55) |
0.001a |
1.36(0.81-2.31) |
0.249 |
| L1cam expression (high/low) | 71/85 | 2.73(1.76-4.25) | <0.001a | 1.94(1.27-4.31) | 0.022a |
aP < 0.05.
bHR, hazard ratio.
cCI, confidence interval.
dSur, Surgery only, Sur + Chemo: Surgery plus adjuvant Chemotherapy.